Volume: 12 Issue: 2
Year: 2024, Page: 47-51, Doi: https://doi.org/10.47799/pimr.1202.09
Received: April 4, 2024 Accepted: May 8, 2024 Published: Aug. 12, 2024
Background: Tuberculosis (TB) remains a significant public health challenge in developing countries, including India, where children under 15 years account for 12% of all TB cases. The National Tuberculosis Elimination Programme (NTEP) recommends the use of GeneXpert/Cartridge-Based Nucleic Acid Amplification Test (CBNAAT) for TB diagnosis, followed by Line Probe Assay (LPA) for detecting drug resistance. This study aimed to determine the prevalence of TB and rifampicin resistance in pediatric patients and to evaluate the utility of CBNAAT in comparison with LPA and Ziehl-Neelsen staining. Methods: This retrospective study was conducted over one year, from 1st January 2022 to 31st December 2022, at a tertiary care hospital in western Maharashtra. A total of 528 samples from pediatric patients (aged <18 years) suspected of having TB were included. Samples underwent CBNAAT testing and Ziehl-Neelsen staining. Positive samples were further analyzed using LPA or Mycobacterial Growth Indicator Tube (MGIT) culture. Results: Among the 528 samples analyzed, gastric lavage accounted for 81.25% of the specimens. CBNAAT detected TB in 61 (11.55%) of the samples, with 15 (24.59%) of these showing rifampicin resistance. Samples with very low or low bacterial loads were often missed by Ziehl-Neelsen staining. Conclusion: Pediatric tuberculosis continues to be a public health concern in developing countries. The study found an 11.55% positivity rate in children under 18 years of age, with 24.59% of positive cases exhibiting rifampicin resistance. The findings underscore the importance of using advanced diagnostic techniques like CBNAAT and highlight the limitations of Ziehl-Neelsen staining in detecting low bacterial loads.
Keywords: GeneXpert, NTEP, Pediatric Tuberculosis, Rifampicin Resistance, LPA
WHO Team Global Tuberculosis Programme (GTB) 2020. World Health Organization. Global Tuberculosis Report 2020. https://www.who.int/publications/i/item/9789240013131
Singh, M P, Sharma, P K, Upadhyay, P, Agrawal, P, Gupta, D K & Verma, V . 2021. A cross sectional study of in-hospital cases of Pediatric Tuberculosis detected by CBNAAT at a tertiary care teaching hospital of Central India. Pediatric Rev Int J Pediatr Res 8(1):39–44.
Kruijshaar, M E & Abubakar, I . 2009. Increase in extrapulmonary tuberculosis in England and Wales. Thorax 64:1090–1095.
Ahmed, T, Sobhan, F, Ahmed, A M, Banu, S, Mahmood, A M & Hyder, K A . 2008. Childhood tuberculosis: a review of epidemiology, diagnosis and management. Infect Dis J Pakistan 17(2):52–60.
Datta, S . 2017. Comparison of sputum collection methods for tuberculosis diagnosis: A systematic review and pairwise and network meta-analysis. The Lancet Global Health 5(8):30201–30203.
Kumar, R, Gupta, A & Aggarwal, A . 2010. Diagnostic accuracy of tuberculin skin test in children with tuberculosis. Indian J Pediatr 77(1):15–18.
Singh, M, Aggarwal, A & Kumar, R . 2010. Role of chest radiography in diagnosis of tuberculosis in children. Indian Pediatr 47(1):15–18.
Yadav, R K . 2020. Cartridge based nucleic acid amplification test: Utility as diagnostic modality in clinically diagnosed childhood tuberculosis. Journal Of Clin And Diagn Res .
Champatiray, J & Patra, G D . 2019. Diagnosis of paediatric tuberculosis by cartridge based nucleic acid amplification test and its effectiveness as compared to the other conventional diagnostic methods. Int J ContempPediatr 6:1204–1214.
William, A, Rai, Y & Kaur, R . 2021. Evaluation of rifampicin-resistant tuberculosis in pediatric patients by GeneXpert MTB/Rif. Journal of Microbiology and Infectious Diseases 11(02):81–87.
Vasumathy, R & Akalya, R . 2020. Clinical profile of childhood tuberculosis and diagnostic efficacy of CBNAAT in tertiary care hospital. IAIM 7(11):23–28.
Raj, A, Baliga, S, Shenoy, M S, Dhanashree, B, Mithra, P P, Nambiar, S K & Sharon, L . 2020. Validity of a CB-NAAT assay in diagnosing tuberculosis in comparison to culture: A study from an urban area of South India. J Clin Tuberc Other Mycobact Dis 21:100198.
Bhatia, R, Dayal, R & Pipariya, D . 2021. Detection of Mycobacterium tuberculosis in Buccal Swab Specimens in Children with Pulmonary Tuberculosis Using Cartridge-based Nucleic Acid Amplification Test. Pediatr Inf Dis 3(4):131–134.
Bangarwa, M . 2023. Role of line probe assay in detection of mycobacterium tuberculosis in children with pulmonary tuberculosis. Indian Journal of Tuberculosis 70.
Rasool, G, Khan, A M, Mohy-Ud-Din, R & Riaz, M . 2019. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert® MTB/RIF assay. Int J ImmunopatholPharmacol 33:2058738419827174.
Jiang, W & Fernandez, M . 2023. Addressing the adherence challenge in tuberculosis treatment: More than digital technologies. Lancet Glob Health 11(5).
Jain, S K, Ordonez, A, Kinikar, A, Gupte, N, Thakar, M, Mave, V, Jubulis, J, Dharmshale, S, Desai, S, Hatolkar, S, Kagal, A, Lalvani, A, Gupta, A & Bharadwaj, R . 2013. Pediatric tuberculosis in young children in India: a prospective study. Biomed Res Int 783698.
©2024 (Pooja Shah) et al. This is an open-access journal, and arƟcles are distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.
Shah P, Pol S, Prabhakaran E, Karmalkar B, Gaikwad V, Dharamshale S, Karyakarte R. Utility of GeneXpert in Diagnosis of Pediatric Tuberculosis and DetecƟon of Rifampicin Resistance. PerspecƟves in Medical Research. 2024;12(02):47-51 DOI: 10.47799/pimr.1202.09